We are live on ! Find out more
ABMD

Abiomed Inc

Delisted

ABMD was delisted on the 21st of December, 2022.

274 hedge funds and large institutions have $3.94B invested in Abiomed Inc in 2016 Q1 according to their latest regulatory filings, with 61 funds opening new positions, 109 increasing their positions, 83 reducing their positions, and 33 closing their positions.

New
Increased
Maintained
Reduced
Closed

423% more call options, than puts

Call options by funds: $51.4M | Put options by funds: $9.84M

85% more first-time investments, than exits

New positions opened: 61 | Existing positions closed: 33

31% more repeat investments, than reductions

Existing positions increased: 109 | Existing positions reduced: 83

10% more funds holding

Funds holding: 249274 (+25)

10% more capital invested

Capital invested by funds: $3.58B → $3.94B (+$358M)

0% more funds holding in top 10

Funds holding in top 10: 88 (0)

Holders
274
Holders Change
+25
Holders Change %
+10.04%
% of All Funds
7.3%
Holding in Top 10
8
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.21%
New
61
Increased
109
Reduced
83
Closed
33
Calls
$51.4M
Puts
$9.84M
Net Calls
+$41.6M
Net Calls Change
+$41M
Name Holding Trade Value Shares
Change
Change in
Stake
Geode Capital Management
251
Geode Capital Management
Massachusetts
$26.9K +$559K +6,626 +2%
EMG
252
ETF Managers Group
New Jersey
$25K +$16.9K +200 New
GWM
253
Geneos Wealth Management
Colorado
$24K +$21.1K +250 New
BJ
254
BlackRock Japan
Japan
$21K
CHP
255
Cable Hill Partners
Oregon
$16K +$3.54K +42 +34%
EWM
256
Evercore Wealth Management
New York
$13K
N
257
Nuveen
North Carolina
$12.9K -$5.38M -63,689 -32%
WCBA
258
Weaver C. Barksdale & Associates
Tennessee
$11K +$10K +119 New
TRCT
259
Tower Research Capital (TRC)
New York
$10K +$8.78K +104 New
MFS
260
MSI Financial Services
Massachusetts
$9K
CLOS
261
Compagnie Lombard Odier SCmA
Switzerland
$8K
QCG
262
Quadrant Capital Group
Ohio
$8K +$8.7K +103 New
FCCM
263
First City Capital Management
Georgia
$7.49K
GAM
264
Gemmer Asset Management
California
$7K +$506 +6 +8%
MA
265
MUFG Americas
New York
$5K +$4.22K +50 New
CCA
266
Checchi Capital Advisers
California
$5K +$4.56K +54 New
FNBT
267
FineMark National Bank & Trust
Florida
$3K
TWA
268
TCI Wealth Advisors
Arizona
$3K +$2.87K +34 New
VIA
269
Vident Investment Advisory
Georgia
$2.36K +$2.11M +24,940 New
EFSCE
270
Enterprise Financial Services Corp (EFSC)
Missouri
$2K +$1.6K +19 New
Acadian Asset Management
271
Acadian Asset Management
Massachusetts
$1K -$4.9K -58 -82%
QI
272
QS Investors
New York
$1K
TCM
273
Tradewinds Capital Management
Washington
$1K
EAM
274
EverPoint Asset Management
Connecticut
-$22.4M -265,000 Closed
FCM
275
Frontier Capital Management
Massachusetts
-$7.29M -80,791 Closed

ABMD Hedge Fund Activity: Q1 2016 in Review

274 of the 3,753 institutional investors tracked by Wall St. Rank reported a position in Abiomed Inc (ABMD) for Q1 2016, worth a combined $3.94B — up 10% from $3.58B a quarter earlier.

Buyers outnumbered sellers: 61 funds opened new ABMD positions and 33 closed out — a net gain of 28 holders — while 109 added to existing stakes and 83 trimmed.

The largest buyer was 1832 Asset Management, opening a new position worth an estimated $67.6M. The largest seller was Essex Woodlands Management, cutting an estimated $59.1M.

  • 274 institutional investors held Abiomed Inc (ABMD) as of Q1 2016, up from 249 in Q4 2015.
  • Funds reported $3.94B of Abiomed Inc stock for Q1 2016, up 10% quarter-over-quarter.
  • 61 funds opened new Abiomed Inc positions in Q1 2016 and 33 closed out, a net change of +28 holders.
  • The largest Abiomed Inc buyer in Q1 2016 was 1832 Asset Management, an estimated $67.6M added.
  • The largest Abiomed Inc seller in Q1 2016 was Essex Woodlands Management, an estimated $59.1M sold.

Based on aggregated 13F filings for Q1 2016.